These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Inotropes in the management of acute heart failure. Petersen JW; Felker GM Crit Care Med; 2008 Jan; 36(1 Suppl):S106-11. PubMed ID: 18158469 [TBL] [Abstract][Full Text] [Related]
27. Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy. Acharya D; Sanam K; Revilla-Martinez M; Hashim T; Morgan CJ; Pamboukian SV; Loyaga-Rendon RY; Tallaj JA Am J Cardiol; 2016 Mar; 117(6):952-6. PubMed ID: 26810859 [TBL] [Abstract][Full Text] [Related]
28. Pulsed inotropic therapy in chronic congestive heart failure: a review of the literature. Woods TD; Prisant LM Am J Ther; 2000 Nov; 7(6):375-80. PubMed ID: 11304645 [TBL] [Abstract][Full Text] [Related]
29. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729 [TBL] [Abstract][Full Text] [Related]
30. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy. Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101 [TBL] [Abstract][Full Text] [Related]
31. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D; Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942 [TBL] [Abstract][Full Text] [Related]
32. Cardiac drugs: new inotropes. Kelleher RM Crit Care Nurs Clin North Am; 1989 Jun; 1(2):391-7. PubMed ID: 2818883 [TBL] [Abstract][Full Text] [Related]
33. Chronic inotropic therapy in end-stage heart failure. Hauptman PJ; Mikolajczak P; George A; Mohr CJ; Hoover R; Swindle J; Schnitzler MA Am Heart J; 2006 Dec; 152(6):1096.e1-8. PubMed ID: 17161059 [TBL] [Abstract][Full Text] [Related]
34. Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure. Levine BS J Cardiovasc Nurs; 2000 Jul; 14(4):76-93. PubMed ID: 10902105 [TBL] [Abstract][Full Text] [Related]
35. "I Just Feel Like I Always Did": Inotropic Dependency at End of Life. Latimer A; Pope ND; McFarlin JM Am J Hosp Palliat Care; 2020 Jul; 37(7):497-502. PubMed ID: 31714150 [TBL] [Abstract][Full Text] [Related]
37. The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation. Thompson KA; Philip KJ; Simsir S; Schwarz ER J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):231-43. PubMed ID: 20595625 [TBL] [Abstract][Full Text] [Related]
38. Inotropes. Francis GS; Bartos JA; Adatya S J Am Coll Cardiol; 2014 May; 63(20):2069-2078. PubMed ID: 24530672 [TBL] [Abstract][Full Text] [Related]
39. Getting to the Heart of the Matter: A Regional Survey of Current Hospice Practices Caring for Patients With Heart Failure Receiving Advanced Therapies. Groninger H; Gilhuly D; Walker KA Am J Hosp Palliat Care; 2019 Jan; 36(1):55-59. PubMed ID: 30037272 [TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. Cesario D; Clark J; Maisel A Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]